The Latest Cardiac and Vascular News
– Findings show intra-vascular access via the radial artery can successfully be used as the primary strategy for the modern embolization practice – SOMERSET, N.J., March 13, 2023 /PRNewswire/ — Terumo Medical Corporation (TMC) is pleased to announce the final results of its […]
Terumo Cardiovascular is a division of Terumo Corporation, a leading medical device company operating in 160+ countries and regions RA’ANANA, Israel, Dec. 27, 2022 /PRNewswire/ — Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the “Company” or “Inspira Technologies”), a groundbreaking respiratory support technology company, announced today that […]
– Researchers used Terumo Health Outcomes’ ePRISM® software to calculate safe contrast volume targets and improve overall patient outcomes – SOMERSET, N.J., Nov. 1, 2022 /PRNewswire/ — A new study published in JAMA[1] demonstrated that patients at high risk for acute kidney injury (AKI), the most […]
– Alignment signals recognition of Terumo Health Outcomes’ proprietary ePRISM® technology using precision medicine to improve outcomes for cardiac patients and Corazon accreditation as a means to monitor and recognize such improvements – SOMERSET, N.J., Feb. 25, 2022 /PRNewswire/ — Terumo Health […]
– Represents the next generation technology for peripheral vascular embolization – SOMERSET, N.J., July 14, 2021 /PRNewswire/ — Terumo Medical Corporation (TMC) has announced today the introduction of its AZUR™ Vascular Plug, the first and only plug compatible with a microcatheter to […]
– Transaction furthers Terumo’s efforts to improve patient outcomes and decrease healthcare costs through personalized predictive analytics and clinical decision support at the point of care – TOKYO, Feb. 23, 2021 /PRNewswire/ — Terumo Corporation (TSE: 4543), a global leader in […]
TOKYO, June 13, 2019 /PRNewswire/ — Terumo Corporation (TSE: 4543), a leading global medical device manufacturer, today announced that it has secured exclusive global development and commercialization rights to Virtue® Sirolimus-Eluting Balloon (SEB) for percutaneous coronary interventions by entering into a strategic partnership with […]
ANN ARBOR, Mich., Jan. 16, 2019 /PRNewswire/ — Terumo Cardiovascular Group, a global leader in cardiovascular surgery technologies, today announced the launch of its smallest full-size adult* oxygenator, the Capiox® NX19 Oxygenator with UltraPrime™ Technology. Terumo began sales of the product in the U.S. and Europe, […]
ANN ARBOR, Mich., Nov. 14, 2018 /PRNewswire/ — Terumo Cardiovascular Group, a global leader in cardiovascular surgery technologies, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the CDI® Blood Parameter Monitoring System 550, adding real-time monitoring of […]
ALISO VIEJO, Calif., May 31, 2018 /PRNewswire/ — MicroVention, Inc., a U.S.-based subsidiary of Terumo and a global neurovascular company, announced today the FDA Premarket Approval (PMA) for the LVIS® and LVIS® Jr. stents for stent-assisted coil embolization of intracranial aneurysms. The LVIS® and LVIS® Jr. […]
